A novel δ-lactam-based histone deacetylase inhibitor, KBH-A42, induces cell cycle arrest and apoptosis in colon cancer cells
- 13 May 2009
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 78 (5) , 486-494
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Histone deacetylases: target enzymes for cancer therapyClinical & Experimental Metastasis, 2007
- Structure−Activity Relationship Studies of a Series of Novel δ-Lactam-Based Histone Deacetylase InhibitorsJournal of Medicinal Chemistry, 2007
- VorinostatNature Reviews Drug Discovery, 2007
- Synthesis, enzymatic inhibition, and cancer cell growth inhibition of novel δ-lactam-based histone deacetylase (HDAC) inhibitorsBioorganic & Medicinal Chemistry Letters, 2006
- Acetylation and deacetylation of non-histone proteinsGene, 2005
- Histone acetylation and diseaseCellular and Molecular Life Sciences, 2001
- Co-activators and co-repressors in the integration of transcriptional responsesCurrent Opinion in Cell Biology, 1998
- Histone acetylation and transcriptional regulatory mechanismsGenes & Development, 1998
- Role of the histone deacetylase complex in acute promyelocytic leukaemiaNature, 1998
- Sinful repressionNature, 1997